Explores the selection and rationale of preclinical animal models in drug development, emphasizing the 10 to 15-year path to a marketed small-molecule drug.
Explores the selection and rationale behind preclinical animal models in drug discovery, emphasizing understanding mechanisms of action and domain specificity.
Explores the legal framework for biomedical research with human beings, covering regulations, authorization, ethical considerations, and challenges in research involving vulnerable populations.
